CardioMech
PrivateLast Round
Convertible Debt
Jan 2, 2024
Total Funding Raised
$39M
Company Overview
CardioMech is a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology for patients with degenerative mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioMech Comparables
Compare CardioMech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoreMedic | 94% | |
| Vesalius Cardiovascular | 93% | |
| Polares Medical | 89% |
CardioMech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jan 2, 2024 | ||||
| Series A | Aug 5, 2020 | ||||
| Convertible Debt | Aug 12, 2019 | ||||
| Convertible Debt | Feb 11, 2019 |
Key People
Founding team and executive leadership
CardioMech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investinor | Convertible Debt, Series A |
| Hadean Ventures | Series A |
Recent news
Latest coverage and updates
- is_developingSep 2, 2026
CardioMech Inc. is developing transcatheter mitral valve repair platform for DMR treatment.
- hiresJun 24, 2026
CardioMech Inc. hired Ramin Mousavi as Chairman of the Board on Jun 24th '26.
- is_developingJun 24, 2026
CardioMech Inc. is developing novel transcatheter mitral valve repair platform.
- hiresJun 24, 2026
CardioMech Inc. hired Ramin as Chairman of the Board on Jun 24th '26.
CardioMech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CardioMech's valuation, stock price, and market status.
Is CardioMech a public or private company?
CardioMech is a private company.
What is the current stock price of CardioMech?
CardioMech is a private company with no public stock price. No recent secondary market data is available.
How much is CardioMech worth (valuation)?
Valuation information for CardioMech is not publicly available.
Can I buy CardioMech stock?
CardioMech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CardioMech's last funding round?
CardioMech's most recent funding round was VC Round on January 2, 2024.
Who are the main investors in CardioMech?
Key investors in CardioMech include Investinor, Hadean Ventures.
Will CardioMech IPO soon?
No public IPO plans have been announced for CardioMech.
How can I track CardioMech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CardioMech's secondary market activity and sign up for updates.